Ok how about this as a starting point?
Amplia Therapeutics Annual Report YE 31/3/23 pg48 “going concern” and audit report pg65
Pharmaxis AR YE 30/6/23 pg33 “going concern” and audit report pg62
Mesoblast AR YE 30/6/24 pg6 “Risks; accumulated deficit $908.8 million; require substantial additional financing” and pg169 “going concern - material uncertainty”
Neuren Pharmaceuticals AR YE 31/12/20 pg36 “material uncertainties and going concern basis”
Actinogen Medical AR YE 30/6/23 pg43 “going concern” and audit report pg64
I think you now owe me an apology and you need to consider retracting your comments in relation to my post!
Ok how about this as a starting point?Amplia Therapeutics Annual...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $29.06K | 131.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 951 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |